The genetic testing
industry, all in one place.
1093+ companies, funding rounds, clinical trials, and breakthroughs — tracked daily for founders, investors, and researchers.
1093+
Companies tracked
across 8 categories
$12B+
Funding tracked
in VC investment
105+
News published
industry articles
Every Sunday
Weekly digest
Genetic Testing Digest
Browse by category
View all 1093 companies →Featured companies
Recently added
百迈客生物
Genetic Testing ·
2bPrecise
Genetic Testing ·
3billion
Genetic Testing ·
Funding spotlight
Population Bio
Series B — approximately $22M raised
Precipio Diagnostics
Publicly traded — NASDAQ: PRPO
Verogen
Acquired by QIAGEN in 2021; previously venture-backed
Fabric Genomics
Private
Reproductive Sciences Medical Center
Private
百迈客生物
Private
Latest news
GRAIL's Galleri blood test, which screens for over 50 cancer types from a single blood draw, is advancing through a pivotal Medicare coverage pathway that could make it available to millions.
New findings show DNA-based tests may miss key lung cancer biomarkers, raising questions about the adequacy of single-modality genomic profiling.
Datar Cancer Genetics receives FDA clearance for CellDx-Tissue, a comprehensive genomic profiling assay for solid tumors using both DNA and RNA.
Experts argue that advances in precision medicine are being bottlenecked by diagnostics that can't yet match therapeutic specificity.
The single-cell multiomics market is forecast to hit $18.20B by 2035, signaling accelerating adoption across clinical and research genomics.
Every Sunday
The Genetic Testing Digest
Funding rounds, breakthroughs, and precision medicine insights — curated weekly for industry professionals.
Subscribe free →For companies
Reach genomics decision-makers
Premium listings, newsletter sponsorships, and featured placements.
View packages →News & insights
All articles →GRAIL's Galleri Multi-Cancer Early Detection Test Advances Toward Broader Medicare Coverage
GRAIL's Galleri blood test, which screens for over 50 cancer types from a single blood draw, is advancing through a pivotal Medicare coverage pathway that could make it available to millions.
2026-06-23
ResearchCertain Lung Cancer Biomarkers Slip Through DNA-Only Testing, Study Warns
New findings show DNA-based tests may miss key lung cancer biomarkers, raising questions about the adequacy of single-modality genomic profiling.
2026-08-06
ProductDatar Cancer Genetics Wins FDA Clearance for Dual DNA+RNA Comprehensive Genomic Profiling Assay
Datar Cancer Genetics receives FDA clearance for CellDx-Tissue, a comprehensive genomic profiling assay for solid tumors using both DNA and RNA.
2026-08-05
1093+
Companies
across 8 sectors
$12B+
VC Invested
tracked in our database
3×/week
News published
Mon · Wed · Fri
35+
Articles
in our archive
Companies by sector
14
Consumer
204
Clinical
23
Oncology
9
Pharmacogenomics
18
Prenatal
0
Ancestry
64
Research
25
Genetic
The Genetic Testing Digest
Funding rounds, product launches, research breakthroughs, and the best jobs — curated weekly for the genetic testing industry.
No spam. Unsubscribe anytime.